September 12, 2017
CTI Clinical Trial & Consulting Services To Present at The Practice of Transplant Administration Workshop
CTI Clinical Trial and Consulting Services (CTI), a multi-national, privately held, full-service contract research organization will present at the 23rd Annual “The Practice of Transplant Administration” Workshop taking place September 11th and 12th in Coronado, California. CTI's Founder and CEO, Timothy J. Schroeder, will present on "Economics of Clinical Trials and their Potential Contributions to the Transplant Program."
"I am honored to be a part of this important workshop on behalf of the TMG," according to Schroeder. "CTI is a leader in the transplant field, with contributions to nearly all transplant-related therapies on the market today."
TMG has held an annual workshop on “The Practice of Transplant Administration” since 1995. Transplant programs from over 160 transplant centers in the country have attended. The two-day workshop focuses on the nuts and bolts of managing the business of transplantation. Timothy Schroeder, CEO and Founder of CTI, has over 35 years of clinical, academic, and industry experience in global drug and device development programs. CTI, founded in 1999, is a multi-national research firm with associates in North America, Europe, Latin America and Asia-Pacific. The firm has supported more than 100 drug and device approvals, and currently works on behalf of approximately 120 global pharmaceutical and biotechnology companies. Prior to founding CTI, Tim held numerous faculty positions with the University of Cincinnati College of Medicine. He was also the founding Executive Vice President of Clinical Development at SangStat Medical Corporation, which went public in 1995. Tim is currently a board member for over a dozen corporate and non-profit organizations, including Xavier University, which he attended. Tim was named as an EY Entrepreneur of the Year in 2015 and was recognized as Top Leader by the Enquirer Media in 2016.
About CTI Clinical Trial and Consulting Services
CTI Clinical Trial and Consulting Services is a global, privately held, full-service contract research organization (CRO), delivering a complete spectrum of clinical trial and consulting services throughout the lifecycle of development, from concept to commercialization. CTI’s focused therapeutic approach provides pharmaceutical, biotechnology, and medical device firms with clinical and disease area expertise in rare diseases, regenerative medicine/gene therapy, immunology, transplantation, nephrology, hematology/oncology, neurology, infectious diseases, hematology, cardiopulmonary, and pediatric populations. CTI also offers a fully integrated multi-specialty clinical research site that conducts phase I-IV trials. CTI has a passion for helping life-changing therapies succeed in chronically and critically ill patient populations. With clinical trial experience across 6 continents, CTI partners with research sites, patients, and sponsors to fulfill unmet medical needs. CTI is headquartered in the Greater Cincinnati, OH area, with operations across North America, Europe, Latin America, and Asia-Pacific. For more information visit www.ctifacts.com